In their 2021 annual letter themed ‘the year global health went local’ released by Bill Gates and Melinda Gates, they are reviewing the epidemic in 2020 and addressing the future.
Gates stressed that cooperation between China and the US is critical to combating the pandemic, including ending the current pandemic and preventing the next one, while he pointed to China’s continuing technological advances, improving regulatory capabilities and a growing willingness to help the world.
Roberta Lipson, founder of United Family Healthcare, agreed that there is plenty of room for cooperation between China and the US, first and foremost in healthcare amid the epidemic’s hardships. High tariffs make the use of imported products more costly for both countries, said Lipson, adding that elimination or reduction of these duties would give patients in both countries access to the most suitable products at reduced costs.
“Opening the market for leading-edge therapies and medicines will also benefit from level playing fields in central procurement as well as reliable intellectual property rights protection,” said Lipson.
In their 2021 annual letter themed ‘the year global health went local’ released by Bill Gates and Melinda Gates, they are reviewing the epidemic in 2020 and addressing the future.
Gates stressed that cooperation between China and the US is critical to combating the pandemic, including ending the current pandemic and preventing the next one, while he pointed to China’s continuing technological advances, improving regulatory capabilities and a growing willingness to help the world.
Roberta Lipson, founder of United Family Healthcare, agreed that there is plenty of room for cooperation between China and the US, first and foremost in healthcare amid the epidemic’s hardships. High tariffs make the use of imported products more costly for both countries, said Lipson, adding that elimination or reduction of these duties would give patients in both countries access to the most suitable products at reduced costs.
“Opening the market for leading-edge therapies and medicines will also benefit from level playing fields in central procurement as well as reliable intellectual property rights protection,” said Lipson.